ASX-Dividend-Report-Banner

Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Sector Update: Health Care Stocks Advance in Afternoon Trading
Market Updates

Sector Update: Health Care Stocks Advance in Afternoon Trading

Health care stocks were higher Friday afternoon, with the NYSE Health Care Index up 0.1% and the Hea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscripti...

  • April 25, 2025 10:58 AM PDT
  • EODHD
Tech Stocks Reclaim Dominance In Elite List Led By Palantir
Market Updates

Tech Stocks Reclaim Dominance In Elite List Led By Palantir

Palantir stock is climbing in a cup base with earnings on the horizon. Netflix stock reached a new high while CrowdStrike broke out. Continue Reading View Comments

  • April 25, 2025 10:52 AM PDT
  • EODHD
Alphabet Offered Hope. What to Expect From the Rest of Big Tech Earnings Next Week.
Market Updates

Alphabet Offered Hope. What to Expect From the Rest of Big Tech Earnings Next Week.

Many of tech’s biggest companies—from Alphabet and Meta Platforms to Amazon and Apple—will report their quarterly results in the coming days. Continue Reading View Comments

  • April 25, 2025 10:47 AM PDT
  • EODHD
Centene Stock Falls on Medicaid Cost Worries
Market Updates

Centene Stock Falls on Medicaid Cost Worries

Health insurer Centene reported strong first-quarter earnings, but shares are slipping on concerns over medical costs. Continue Reading View Comments

  • April 25, 2025 10:38 AM PDT
  • EODHD
Construction Stock Argan Builds New Base; Nears Entry As Profits Surge 196%
Market Updates

Construction Stock Argan Builds New Base; Nears Entry As Profits Surge 196%

The future will need more electrical power as artificial intelligence boosts data center demand. Construction stock Argan is expected to benefit. Continue Reading View Comments

  • April 25, 2025 10:26 AM PDT
  • EODHD
Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss
Market Updates

Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss

As part of today's Market Minute, Julie Hyman examines some of the top stories investors are watching. Bitcoin (BTC-USD) climbs above the $95,000 mark as investors weigh macroeconomic uncertainties. A...

  • April 25, 2025 10:11 AM PDT
  • EODHD
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
Market Updates

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in p...

  • April 25, 2025 10:00 AM PDT
  • EODHD
DTE Completes Construction on Pine River Solar Park
Market Updates

DTE Completes Construction on Pine River Solar Park

Approximately 20,000 homes to be powered with clean, renewable energy from DTE's Pine River Solar Park when fully online this spring Detroit, April 25, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE:DTE),...

  • April 25, 2025 10:00 AM PDT
  • EODHD
Microsoft is releasing Windows recall tool after security fixes
Market Updates

Microsoft is releasing Windows recall tool after security fixes

(Bloomberg) — Microsoft Corp. is rolling out its controversial Recall feature to high-end Windows PCs, betting a record of what users do on their computers will be seen as more of a benefit than a pri...

  • April 25, 2025 10:00 AM PDT
  • EODHD
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
Market Updates

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity acr...

  • April 25, 2025 10:00 AM PDT
  • EODHD
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.